These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 18836444)
21. Epigenetic modification and uniparental inheritance of H19 in Beckwith-Wiedemann syndrome. Catchpoole D; Lam WW; Valler D; Temple IK; Joyce JA; Reik W; Schofield PN; Maher ER J Med Genet; 1997 May; 34(5):353-9. PubMed ID: 9152830 [TBL] [Abstract][Full Text] [Related]
22. Frequency and timing of loss of imprinting at 11p13 and 11p15 in Wilms' tumor development. Brown KW; Power F; Moore B; Charles AK; Malik KT Mol Cancer Res; 2008 Jul; 6(7):1114-23. PubMed ID: 18644976 [TBL] [Abstract][Full Text] [Related]
23. Role of genomic imprinting in Wilms' tumour and overgrowth disorders. Reeve AE Med Pediatr Oncol; 1996 Nov; 27(5):470-5. PubMed ID: 8827076 [TBL] [Abstract][Full Text] [Related]
24. Clinical characteristics and chromosome 11p15 imprinting analysis of Silver-Russell syndrome - a Chinese experience. Wu D; Gong C; Zheng H; Saenger P; Zhao Y; Gu Y; Cao B; Li W; Su C J Pediatr Endocrinol Metab; 2014 Nov; 27(11-12):1113-20. PubMed ID: 24945423 [TBL] [Abstract][Full Text] [Related]
26. High frequency of copy number variations (CNVs) in the chromosome 11p15 region in patients with Beckwith-Wiedemann syndrome. Baskin B; Choufani S; Chen YA; Shuman C; Parkinson N; Lemyre E; Micheil Innes A; Stavropoulos DJ; Ray PN; Weksberg R Hum Genet; 2014 Mar; 133(3):321-30. PubMed ID: 24154661 [TBL] [Abstract][Full Text] [Related]
27. Analysis of the IGF2/H19 imprinting control region uncovers new genetic defects, including mutations of OCT-binding sequences, in patients with 11p15 fetal growth disorders. Demars J; Shmela ME; Rossignol S; Okabe J; Netchine I; Azzi S; Cabrol S; Le Caignec C; David A; Le Bouc Y; El-Osta A; Gicquel C Hum Mol Genet; 2010 Mar; 19(5):803-14. PubMed ID: 20007505 [TBL] [Abstract][Full Text] [Related]
28. Altered expression of imprinted genes in Wilms tumors. Hubertus J; Lacher M; Rottenkolber M; Müller-Höcker J; Berger M; Stehr M; von Schweinitz D; Kappler R Oncol Rep; 2011 Mar; 25(3):817-23. PubMed ID: 21174059 [TBL] [Abstract][Full Text] [Related]
29. Novel deletion in 11p15.5 imprinting center region 1 in a patient with Beckwith-Wiedemann syndrome provides insight into distal enhancer regulation and tumorigenesis. Bachmann N; Crazzolara R; Bohne F; Kotzot D; Maurer K; Enklaar T; Prawitt D; Bergmann C Pediatr Blood Cancer; 2017 Mar; 64(3):. PubMed ID: 27650505 [TBL] [Abstract][Full Text] [Related]
34. Epigenetic changes at the insulin-like growth factor II/H19 locus in developing kidney is an early event in Wilms tumorigenesis. Okamoto K; Morison IM; Taniguchi T; Reeve AE Proc Natl Acad Sci U S A; 1997 May; 94(10):5367-71. PubMed ID: 9144243 [TBL] [Abstract][Full Text] [Related]
35. Loss of imprinting of insulin-like growth factor-II in Wilms' tumor commonly involves altered methylation but not mutations of CTCF or its binding site. Cui H; Niemitz EL; Ravenel JD; Onyango P; Brandenburg SA; Lobanenkov VV; Feinberg AP Cancer Res; 2001 Jul; 61(13):4947-50. PubMed ID: 11431321 [TBL] [Abstract][Full Text] [Related]
36. Paradoxical NSD1 mutations in Beckwith-Wiedemann syndrome and 11p15 anomalies in Sotos syndrome. Baujat G; Rio M; Rossignol S; Sanlaville D; Lyonnet S; Le Merrer M; Munnich A; Gicquel C; Cormier-Daire V; Colleaux L Am J Hum Genet; 2004 Apr; 74(4):715-20. PubMed ID: 14997421 [TBL] [Abstract][Full Text] [Related]
37. Biallelic expression of HRAS and MUCDHL in human and mouse. Goldberg M; Wei M; Yuan L; Murty VV; Tycko B Hum Genet; 2003 Apr; 112(4):334-42. PubMed ID: 12589428 [TBL] [Abstract][Full Text] [Related]
38. No evidence for additional imprinting defects in Silver-Russell syndrome patients with maternal uniparental disomy 7 or 11p15 epimutation. Schönherr N; Meyer E; Binder G; Wollmann HA; Eggermann T J Pediatr Endocrinol Metab; 2007 Dec; 20(12):1329-31. PubMed ID: 18341093 [TBL] [Abstract][Full Text] [Related]